Androgen receptor overexpression in prostate cancer in type 2 diabetes

Autor: Lutz, S.Z., Hennenlotter, J., Scharpf, M.O., Sailer, C., Fritsche, L., Schmid, V., Kantartzis, K., Wagner, R., Lehmann, R., Berti, L., Peter, A., Staiger, H., Fritsche, A., Fend, A., Todenhöfer, T., Stenzl, A., Häring, H.-U., Heni, M.

Publikováno v: Molecular Metabolism, Vol 8, Iss, Pp 158-166 (2018)
Molecular Metabolism
Mol. Metab. 8, 158-166:doi:10.1016/j.molmet.2017.11.013 (2017)

Objective While prostate cancer does not occur more often in men with diabetes, survival is markedly reduced in this patient group. Androgen signaling is a known and major driver for prostate cancer progression. Therefore, we analyzed major component

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::dbbf37fcad2fa13131b37a333a6ed1d8
http://www.sciencedirect.com/science/article/pii/S2212877817306841